Clinical trial
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation…
NCT00083681 · University of Arkansas, Other · Completed
Key facts
| NCT number | NCT00083681 |
|---|---|
| Title | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse |
| Official title | UARK 98-018, A Randomized Phase II Trial of DCEP or DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse in Patients With Multiple Myeloma |
| Lead sponsor | University of Arkansas, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Thalidomide, Dexamethasone, Cytoxan, Etoposide, Cisplatin, G-CSF |
| Enrollment | 180 |
| Start date | Jun 1, 1998 |
| Completion | May 1, 2005 |
| First posted | May 28, 2004 |
| Last update posted | Jul 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: